Cerep, to provide profiling services to support a drug discovery program for Spinal Muscular Atrophy

Paris, France, January 31 , 2008 – Cerep [Eurolist: Cerep] is pleased to announce that it has been selected by Science Applications International Corporation (SAIC) on behalf of the Spinal Muscular Atrophy (SMA) Project through the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health to provide in vitro pharmacological profiling and ADME/Tox services for a multi-year program... english [PDF] Cerep's Press Release - français [PDF] Communiqué de Presse Cerep-